Variable Platelet Response to Aspirin and Clopidogrel in Atherothrombotic Disease

This publication has 90 references indexed in Scilit:

• Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets
  Biochemical Journal, 2006
• Effect of Enteric Coating on Antiplatelet Activity of Low-Dose Aspirin in Healthy Volunteers
  Stroke, 2006
• The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts
  Proceedings of the National Academy of Sciences, 2006
• Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: Results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial
  American Heart Journal, 2006
• De Novo Synthesis of Cyclooxygenase-1 Counteracts the Suppression of Platelet Thromboxane Biosynthesis by Aspirin
  Circulation Research, 2006
• Analysis of Risk of Bleeding Complications After Different Doses of Aspirin in 192,036 Patients Enrolled in 31 Randomized Controlled Trials
  The American Journal of Cardiology, 2005
• Coronary syndromes following aspirin withdrawal
  Journal of the American College of Cardiology, 2005
• Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?
  American Heart Journal, 2004
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• Platelet Activation in Unstable Coronary Disease
  New England Journal of Medicine, 1986